A congressional committee has scheduled a hearing for next week focused on the Food and Drug Administration’s (FDA) refusal to enact regulations to allow for the marketing of hemp-derived CBD products. And bipartisan and bicameral lawmakers have separately reintroduced a bill to fill the regulatory gap. The House Oversight and Accountability Subcommittee on Health Care … Continue reading Congressional Committee Schedules Hearing To Press FDA On Lack Of CBD Regulations Next Week As Bipartisan Lawmakers File Bills To Address The Issue